If approved, AZN's Fasenra will be the second biologic approved in the European Union to treat eosinophilic granulomatosis with polyangiitis.
Vous n'êtes pas connecté
If approved, the RSV vaccine will be Moderna's (MRNA) second approved product in the European Union.
If approved, AZN's Fasenra will be the second biologic approved in the European Union to treat eosinophilic granulomatosis with polyangiitis.
Sunscreen will be cheaper in Costa Rica after 33 deputies approved a bill in its second debate that lowers the Value Added Tax (VAT) for this product....
Moderna doses the first participant in a phase III study evaluating its mRNA norovirus vaccine candidate, mRNA-1403, in the United States.
For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus...
The new insurance product is to outperform Indian large cap portfolios, which has become a challenge in general, mirroring western capital market...
The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.
FRIDAY, Sept. 27, 2024 -- In the 2023 to 2024 respiratory syncytial virus (RSV) season, more than half of infants were protected by maternal RSV...
Grenada will host the second European union-Caribbean global gateway conference on sargassum early next month.
INFECTIOUS disease specialist Dr Peter Chin Hong says other than not being vaccinated, the biggest threat to people in this phase of covid19 is...
20 September 2024 -- FluMist has been approved in the US as the only self-administered influenza vaccine. FluMist, a needle-free nasal spray, was...